Vascarta’s VAS-101 has demonstrated improved preservation of stored red blood cells, extending their lifespan in circulation. Ex vivo and in vivo studies conducted at the FDA and UC San Diego highlight its potential to enhance transfusion efficacy and patient outcomes.